Answers are grounded in this paper and cite their sources.
Metabolism remodeling in pancreatic ductal adenocarcinoma – INTRODUCTION Pancreatic ductal adenocarcinoma (PDAC) is a tumor with early metastatic potential and remarkable resistance to established therapies such as chemotherapy, radiotherapy, and molecular targeted therapy [1]. Given primary localization and cell morphology, PDAC has been generally viewed to be originated from pancreatic ductal cells. Nevertheless, dozens of studies including lineage tracing propose alternative original sources (...)
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: